The FDA’s new Commissioner’s National Priority Voucher signals a transformative shift in U.S. drug review, tying accelerated approval to manufacturing readiness, domestic supply-chain strength, and ...

Panera unveils "RISE" strategy to boost stagnant sales growth, targeting $7 billion in systemwide revenue by 2028 through a ...